Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy-Reference-Cited by-同舟云学术

Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy

Published:2021-09-21 Issue:7885 Volume:599 Page:465-470
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Yamin Rachel,Jones Andrew T.^ORCID,Hoffmann Hans-Heinrich^ORCID,Schäfer Alexandra,Kao Kevin S.,Francis Rebecca L.,Sheahan Timothy P.^ORCID,Baric Ralph S.^ORCID,Rice Charles M.^ORCID,Ravetch Jeffrey V.^ORCID,Bournazos Stylianos^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/s41586-021-04017-w.pdf

Reference37 articles.

1. Chen, P. et al. SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19. N. Engl. J. Med. 384, 229–237 (2021).

2. Weinreich, D. M. et al. REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N. Engl. J. Med. 384, 238–251 (2021).

3. Gottlieb, R. L. et al. Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: a randomized clinical trial. JAMA 325, 632–644 (2021).

4. Taylor, P. C. et al. Neutralizing monoclonal antibodies for treatment of COVID-19. Nat. Rev. Immunol. 21, 382–393 (2021).

5. Lundgren, J. D. et al. A neutralizing monoclonal antibody for hospitalized patients with Covid-19. N. Engl. J. Med. 384, 905–914 (2021).

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fc‐FcγR interactions during infections: From neutralizing antibodies to antibody‐dependent enhancement;Immunological Reviews;2024-09-13

2. The function of antibodies;Immunological Reviews;2024-08-24

3. Antibody‐mediated control mechanisms of viral infections;Immunological Reviews;2024-08-20

4. Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responses;PLOS Pathogens;2024-08-15

5. Protective non-neutralizing SARS-CoV-2 monoclonal antibodies;Trends in Immunology;2024-08